The Net Margin of Samsung Biologics Co Ltd (207940.KS) is 23.82%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | 23.82% |
2023-12-31 | 23.21% |
2022-12-31 | 26.59% |
2021-12-31 | 25.10% |
2020-12-31 | 20.69% |
2019-12-31 | 28.92% |
2018-12-31 | 41.83% |
2017-12-31 | -20.87% |
2016-12-31 | -60.02% |
2015-12-31 | 2103.66% |